Pixantrone beyond monotherapy:a review

Autor: Silvina Grasso Cicala, Francesco d'Amore, Clara Alonso Caballero, Judit Jørgensen, Thomas Stauffer Larsen, Cristina Barrenetxea Lekue, Susana Herráez Rodríguez, Helle Toldbod, Sirpa Leppä, Irene Leal Martinez

Publikováno v: Barrenetxea Lekue, C, Grasso Cicala, S, Leppä, S, Stauffer Larsen, T, Herráez Rodríguez, S, Alonso Caballero, C, Jørgensen, J M, Toldbod, H, Leal Martínez, I & D’Amore, F 2019, ' Pixantrone beyond monotherapy : a review ', Annals of Hematology, vol. 98, no. 9, pp. 2025-2033 . https://doi.org/10.1007/s00277-019-03749-0
Annals of Hematology

Outcomes for patients with non-Hodgkin’s lymphoma (NHL) that proves refractory to treatment remain poor. Treatment of such patients is individualized and can include enrolment in a clinical trial of novel agents or use of one of a wide array of dru

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660418f1ff8c4927ca50b28e0dde538f
https://findresearcher.sdu.dk:8443/ws/files/153162135/Pixantrone_beyond_monotherapy.pdf